Journal
ANALYTICAL CHEMISTRY
Volume 94, Issue 20, Pages 7278-7285Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.2c00554
Keywords
-
Categories
Funding
- NIH [1U01AA029316]
Ask authors/readers for more resources
In this study, researchers identified a new DNA aptamer (SNAP4) that binds with high affinity to the SARS-CoV-2 spike protein. AptaFlow, a lateral flow assay using both SNAP1 and SNAP4, was able to detect UV-inactivated SARS-CoV-2 virus at concentrations as low as 106 copies/mL.
The COVID-19 pandemic is among the greatest health and socioeconomic crises in recent history. Although COVID-19 vaccines are being distributed, there remains a need for rapid testing to limit viral spread from infected individuals. We previously identified the SARS-CoV-2 spike protein N-terminal domain (NTD) binding DNA aptamer 1 (SNAP1) for detection of SARS-CoV-2 virus by aptamer-antibody sandwich enzyme-linked immunoassay (ELISA) and lateral flow assay (LFA). In this work, we identify a new aptamer that also binds at the NTD, named SARS-CoV-2 spike protein NTD-binding DNA aptamer 4 (SNAP4). SNAP4 binds with high affinity (<30 nM) for the SARS-CoV-2 spike protein, a 2-fold improvement over SNAP1. Furthermore, we utilized both SNAP1 and SNAP4 in an aptamer sandwich LFA (AptaFlow), which detected SARS-CoV-2 UV-inactivated virus at concentrations as low as 106 copies/mL. AptaFlow costs <$1 per test to produce, provides results in <1 h, and detects SARS-CoV-2 at concentrations that indicate higher viral loads and a high probability of contagious transmission. AptaFlow is a potential approach for a low-cost, convenient antigen test to aid the control of the COVID-19 pandemic.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available